BCAL Diagnostics Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BDX.AX research report →
Price Chart
About the company
BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells.
- CEO
- Anne-Louise Arnett
- IPO
- 2021
- Employees
- 6
- HQ
- Sydney, NSW, AU
Get TickerSpark's AI analysis on BDX.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $21.38M
- P/E
- -2.91
- PEG
- -0.12
- P/S
- 16.35
- P/B
- 8.50
- EV/EBITDA
- -2.82
- Div Yield
- 0.00%
- Gross Margin
- 70.04%
- Op Margin
- -601.40%
- Net Margin
- -547.43%
- ROE
- -164.22%
- ROIC
- -86.47%
Latest fiscal year · YoY change
- Revenue
- $21.64K-99.3%
- Gross Profit
- $21.64K-99.3%
- Op Income
- $-9,962,331
- Net Income
- $-7,241,035-13.1%
- EPS
- $-0.02+22.7%
- OCF Growth
- -35.7%
- FCF Growth
- -22.0%
- 52W High
- $0.15
- 52W Low
- $0.05
- 50D MA
- $0.07
- 200D MA
- $0.09
- Beta
- 0.81
- RSI (14)
- 40
- Avg Volume
- 356.56K
No earnings-call transcripts are available for BDX.AX yet.
- Free Float
- 48.5%
- Shares Outstanding
- 368.68M
- Float Shares
- 178.81M
Our BDX.AX coverage
Recent articles, reports, and earnings notes.
No research on BDX.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BDX.AX report →